Michael O Sullivan - 29 Jul 2022 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role: Chief Financial Officer
Signature: /s/ Mark A. Catchur, as Attorney-in-Fact for Michael O. Sullivan
Issuer symbol: OGEN
Transactions as of: 29 Jul 2022
Net transactions value: $0
Form type: 4
Filing time: 02 Aug 2022, 16:38:15 UTC
Previous filing: 24 Jun 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGEN	Employee Stock Option (Right to Buy)	Award	$0	+200,000		$0.000000	200,000	29 Jul 2022	Common Stock	200,000	$0.3562	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, July 29, 2022.

Content

Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, July 29, 2022.